Enhancing Chimeric Antigen Receptor T cell therapy in Mouse EGFRvIII Heterogeneous Glioblastoma

dc.contributor.advisor

Bellamkonda, Ravi V

dc.contributor.author

Swan, Sheridan Leigh-Carroll

dc.date.accessioned

2023-06-08T18:19:53Z

dc.date.available

2023-06-08T18:19:53Z

dc.date.issued

2023

dc.department

Biomedical Engineering

dc.description.abstract

Chimeric antigen receptor (CAR) T cell therapy for glioblastoma remains challenging due to insufficient CAR T cell abundance and antigen-negative tumor cells evading targeting. Unfortunately, most preclinical studies evaluating CAR T cells in glioblastoma use tumors expressing a single antigen, xenografts, and/or lymphodepletion. While lymphodepletion enhances CAR T cell efficacy, it diminishes the endogenous immune system, which has the potential for tumor eradication. Here, we orthotopically delivered IL7 and/or Flt3L expressing CAR T cells in 50% EGFRvIII-positive and -negative tumors pre-conditioned with non-lymphodepleting irradiation. IL7 and IL7 Flt3L CAR T cells increased intratumoral CD8 CAR T cell populations seven days after treatment. IL7 co-expression with Flt3L increased conventional dendritic cells (cDCs) as well as the CD103+XCR1+ population known for migration and antigen cross-presentation. Treatment with IL7 or IL7 Flt3L CAR T cells improved overall survival to 67% and 50%, respectively, compared to 9% in vCAR and vFL and no survivors in PBS treated. However, there was no significant difference in survival between IL7 and IL7 Flt3L CAR T cells. We conclude that CAR T cells modified to express IL7 demonstrate therapeutic potential in glioblastoma treated with non-lymphodepleting irradiation and co-expression with Flt3L modestly improved intratumoral dendritic cell populations.

dc.identifier.uri

https://hdl.handle.net/10161/27581

dc.subject

Immunology

dc.subject

Biomedical engineering

dc.subject

CAR T cells

dc.subject

dendritic cells

dc.subject

Flt3L

dc.subject

Glioblastoma

dc.subject

IL7

dc.subject

T cell abundance

dc.title

Enhancing Chimeric Antigen Receptor T cell therapy in Mouse EGFRvIII Heterogeneous Glioblastoma

dc.type

Dissertation

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Swan_duke_0066D_17114.pdf
Size:
3.22 MB
Format:
Adobe Portable Document Format

Collections